GHP is jump-starting a partnership with Nicaragua’s Ministry of Health and the U.S.-based Global Coalition Against Cervical Cancer (GC3) to develop a national program of cervical cancer prevention, screening and treatment. Nicaragua has an extremely high mortality rate from this preventable disease, a tragedy that does not exist in developed countries. There are approximately 750,000 women in Nicaragua currently in need of cervical cancer screening, with another 250,000 women who will require screening in the next five years. GHP and GC3 will provide cervical cancer specialists and experts to collaborate with and support Nicaragua’s Health Ministry.
Our goals include strategic planning and support for national expansion of human papillomavirus (HPV) testing-based screening; organizing training for diagnosis, management, and